Log in to save to my catalogue

Relapse after complete response in newly diagnosed multiple myeloma: implications of duration of res...

Relapse after complete response in newly diagnosed multiple myeloma: implications of duration of res...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2120755824

Relapse after complete response in newly diagnosed multiple myeloma: implications of duration of response and patterns of relapse

About this item

Full title

Relapse after complete response in newly diagnosed multiple myeloma: implications of duration of response and patterns of relapse

Publisher

London: Nature Publishing Group UK

Journal title

Leukemia, 2019-03, Vol.33 (3), p.730-738

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Achieving a complete response (CR) is associated with improved overall survival (OS) in multiple myeloma (MM), but data on duration of CR (DurCR) are limited. We evaluated 351 patients (2004–2016), achieving CR with first-line therapy. Patients with sustained DurCR ≥ 24 months (
n
 = 177) had better OS; 150 vs. 81 months,
p
 < 0.001. Du...

Alternative Titles

Full title

Relapse after complete response in newly diagnosed multiple myeloma: implications of duration of response and patterns of relapse

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2120755824

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2120755824

Other Identifiers

ISSN

0887-6924

E-ISSN

1476-5551

DOI

10.1038/s41375-018-0271-1

How to access this item